Previously, we and others have revealed distinct AR chromatin binding profiles between healthy tissue and primary prostate cancer17 as well as between primary prostate cancer and castration resistant prostate cancer (CRPC)18, which successfully stratified patients on outcome. The gene discussed is AR; the disease is prostate cancer.